Log In
BCIQ
Print this Print this
 

Testopel

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionTestosterone pellet
Molecular Target
Mechanism of ActionHormone replacement therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat male hypogonadism
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$658.1M

$585.0M

$50.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/29/2013

$658.1M

$585.0M

$50.0M

Get a free BioCentury trial today